Review
doi: 10.1159/000024971.
DNA vaccines
Affiliations
- PMID: 10516466
- DOI: 10.1159/000024971
Item in Clipboard
Review
DNA vaccines
Intervirology.
1999.
Abstract
Chronic infections with hepatitis B (HBV) and hepatitis C (HCV) virus are worldwide problems often leading to the development of chronic liver disease and hepatocellular carcinoma. Genetic immunizations with DNA encoding for structural and nonstructural proteins of HCV and HBV in experimental mice generate a broad base CD4+ and CD8+ cellular immune response which may be required for viral clearance from the host. DNA based immunization is a promising antiviral approach for the development of therapeutic and prophylactic vaccine against HBV and HCV.
Similar articles
-
A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.J Virol. 2015 Aug;89(15):7991-8002. doi: 10.1128/JVI.00803-15. Epub 2015 May 27. J Virol. 2015. PMID: 26018154 Free PMC article.
-
DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.Vaccine. 2013 Dec 5;31(50):5968-74. doi: 10.1016/j.vaccine.2013.10.037. Epub 2013 Oct 19. Vaccine. 2013. PMID: 24144476
-
Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.J Virol. 2019 Sep 12;93(19):e00202-19. doi: 10.1128/JVI.00202-19. Print 2019 Oct 1. J Virol. 2019. PMID: 31292249 Free PMC article.
-
Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses.Transfus Clin Biol. 2001 Dec;8(6):467-70. doi: 10.1016/s1246-7820(01)00200-2. Transfus Clin Biol. 2001. PMID: 11802608 Review.
-
DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.Intervirology. 2001;44(2-3):78-87. doi: 10.1159/000050035. Intervirology. 2001. PMID: 11509869 Review.
Cited by
-
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.Clin Exp Immunol. 2005 Nov;142(2):362-9. doi: 10.1111/j.1365-2249.2005.02919.x. Clin Exp Immunol. 2005. PMID: 16232225 Free PMC article.
-
Evaluation of a novel non-penetrating electrode for use in DNA vaccination.PLoS One. 2011 Apr 29;6(4):e19181. doi: 10.1371/journal.pone.0019181. PLoS One. 2011. PMID: 21559474 Free PMC article.
-
Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.World J Gastroenterol. 2006 Nov 28;12(44):7118-25. doi: 10.3748/wjg.v12.i44.7118. World J Gastroenterol. 2006. PMID: 17131473 Free PMC article.
-
Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment.World J Gastroenterol. 2006 Jul 21;12(27):4420-4. doi: 10.3748/wjg.v12.i27.4420. World J Gastroenterol. 2006. PMID: 16865790 Free PMC article. Clinical Trial.
-
CCHFV vaccine development, current challenges, limitations, and future directions.Front Immunol. 2023 Sep 11;14:1238882. doi: 10.3389/fimmu.2023.1238882. eCollection 2023. Front Immunol. 2023. PMID: 37753088 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
